Passage Bio Reports Updated Interim Data from upliFT-D Trial and Provides Regulatory and Corporate Updates
Go back to Passage Bio Reports Updated Interim Data from upliFT-D Trial and Provides Regulatory and Corporate Updates| (NASDAQ: PASG) | Delayed: 5.59 +0.26 (4.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.33 | 52 Week High | $ | |||
| Open | $5.34 | 52 Week Low | $ | |||
| Day High | $5.65 | P/E | N/A | |||
| Day Low | $5.27 | EPS | $ | |||
| Volume | 73,070 | |||||
| (NASDAQ: PASG) | Delayed: 5.59 +0.26 (4.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.33 | 52 Week High | $ | |||
| Open | $5.34 | 52 Week Low | $ | |||
| Day High | $5.65 | P/E | N/A | |||
| Day Low | $5.27 | EPS | $ | |||
| Volume | 73,070 | |||||
